Comparison of the effect of intra-dermal injection of botulinum toxin and normal saline in the treatment of facial skin pores.
TL;DR
It can be concluded that intra-dermal injection of botulinum toxin is an effective and safe method to control facial pores, which showed acceptable results after 3 months.
OpenAlex 토픽 ·
Dermatologic Treatments and Research
Botulinum Toxin and Related Neurological Disorders
Sympathectomy and Hyperhidrosis Treatments
It can be concluded that intra-dermal injection of botulinum toxin is an effective and safe method to control facial pores, which showed acceptable results after 3 months.
APA
Nader Pazyar, Saeed Ashoori, et al. (2024). Comparison of the effect of intra-dermal injection of botulinum toxin and normal saline in the treatment of facial skin pores.. Journal of family medicine and primary care, 13(5), 1797-1803. https://doi.org/10.4103/jfmpc.jfmpc_1327_23
MLA
Nader Pazyar, et al.. "Comparison of the effect of intra-dermal injection of botulinum toxin and normal saline in the treatment of facial skin pores.." Journal of family medicine and primary care, vol. 13, no. 5, 2024, pp. 1797-1803.
PMID
38948607
Abstract
[BACKGROUND AND PURPOSE] Skin pores (SPs) are normal and benign skin structures that are mostly located on the face (nose, cheeks, etc.) that cause many aesthetic concerns or complaints. One known effective treatment is botulinum toxin A (BTXA), which is also approved for the treatment of strabismus, blepharospasm, muscle spasm, cervical dystonia, glabella wrinkles, and primary axillary hyperhidrosis. Therefore, the aim of this study was to compare the effect of intra-dermal injection of botulinum toxin and normal saline serum (NSS) in the treatment of large facial pores.
[METHODS] The study included 25 people who referred to the skin clinic of Imam Khomeini Hospital in Ahvaz from June 2021 to January 2022 for the treatment of large facial skin pores. Randomly, some subjects were injected with botulinum toxin at ten points, and each point was equivalent to 2.5 units of Masport (500 units vial of Masport diluted with 10 ml of NSS). Some other people were injected with 0.05 ml of NSS by intra-dermal injection at ten points. Finally, the data were analyzed using SPSS-Ver. 22 software.
[RESULTS] Based on optical coherence tomography results, it was determined that the diameter of facial pores decreased significantly ( = 0.011). Dermoscopy showed a significant decrease in the average size of facial pores ( < 0.011), and also, the pore score decreased significantly ( = 0.021). In addition, the results showed that the size of skin pores and facial fat on both sides of the face did not decrease significantly from the patients' point of view ( = 0.71).
[CONCLUSION] Based on the results of the present study, it can be concluded that intra-dermal injection of botulinum toxin is an effective and safe method to control facial pores, which showed acceptable results after 3 months.
[METHODS] The study included 25 people who referred to the skin clinic of Imam Khomeini Hospital in Ahvaz from June 2021 to January 2022 for the treatment of large facial skin pores. Randomly, some subjects were injected with botulinum toxin at ten points, and each point was equivalent to 2.5 units of Masport (500 units vial of Masport diluted with 10 ml of NSS). Some other people were injected with 0.05 ml of NSS by intra-dermal injection at ten points. Finally, the data were analyzed using SPSS-Ver. 22 software.
[RESULTS] Based on optical coherence tomography results, it was determined that the diameter of facial pores decreased significantly ( = 0.011). Dermoscopy showed a significant decrease in the average size of facial pores ( < 0.011), and also, the pore score decreased significantly ( = 0.021). In addition, the results showed that the size of skin pores and facial fat on both sides of the face did not decrease significantly from the patients' point of view ( = 0.71).
[CONCLUSION] Based on the results of the present study, it can be concluded that intra-dermal injection of botulinum toxin is an effective and safe method to control facial pores, which showed acceptable results after 3 months.
추출된 의학 개체 (NER)
| 유형 | 영어 표현 | 한국어 / 풀이 | UMLS CUI | 출처 | 등장 |
|---|---|---|---|---|---|
| 시술 | botulinum toxin
|
보툴리눔독소 주사 | dict | 5 | |
| 해부 | intra-dermal
|
scispacy | 1 | ||
| 해부 | muscle
|
scispacy | 1 | ||
| 해부 | cervical
|
scispacy | 1 | ||
| 해부 | serum
|
scispacy | 1 | ||
| 해부 | skin
|
scispacy | 1 | ||
| 해부 | facial fat
|
scispacy | 1 | ||
| 해부 | facial pores
|
scispacy | 1 | ||
| 합병증 | nose
|
scispacy | 1 | ||
| 합병증 | cheeks
|
scispacy | 1 | ||
| 합병증 | glabella wrinkles
|
scispacy | 1 | ||
| 약물 | NSS
→ normal saline serum
|
scispacy | 1 | ||
| 약물 | saline
|
scispacy | 1 | ||
| 약물 | [BACKGROUND AND PURPOSE] Skin pores
|
scispacy | 1 | ||
| 약물 | [RESULTS] Based
|
scispacy | 1 | ||
| 약물 | [CONCLUSION] Based
|
scispacy | 1 | ||
| 질환 | strabismus
|
C0038379
Strabismus
|
scispacy | 1 | |
| 질환 | blepharospasm
|
C0005747
Blepharospasm
|
scispacy | 1 | |
| 질환 | muscle spasm
|
C0037763
Spasm
|
scispacy | 1 | |
| 질환 | dystonia
|
C0013421
Dystonia
|
scispacy | 1 | |
| 질환 | hyperhidrosis
|
C0020458
Hyperhidrosis disorder
|
scispacy | 1 | |
| 질환 | NSS
→ normal saline serum
|
scispacy | 1 | ||
| 질환 | SPs
→ Skin pores
|
scispacy | 1 | ||
| 질환 | benign skin structures
|
scispacy | 1 | ||
| 기타 | BTXA
→ botulinum toxin A
|
scispacy | 1 | ||
| 기타 | axillary
|
scispacy | 1 | ||
| 기타 | people
|
scispacy | 1 | ||
| 기타 | skin pores
|
scispacy | 1 |
🔗 함께 등장하는 도메인
이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들
관련 논문
- Local therapeutic strategies for neurocutaneous dysesthesia: from capsaicin to cannabinoids.
- Comparative efficacy of intralesional therapies for keloid scars: a network meta-analysis.
- Adverse neurological events following botulinum toxin type A: A case series of post-injection seizures and paralysis.
- Decreased utilization of component separation techniques over time in complex abdominal wall reconstruction following introduction of preoperative botulinum toxin A.
- Current Perspectives on Pectoralis Minor Syndrome: A Narrative Review.